Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Peña, M; Losi, G; Navarro, V; Qualls, DA; Crombie, JL; Mariotti, J; Bramanti, S; Fabbri, N; Serna, A; Serroukh, YIM; Balaguer-Rosselló, A; Van Der Poel, MWM; Hsu, YT; Jiménez-Ubieto, A; McKinnely, C; López-Corral, L; Panizo, C; Pérez-Simón, JA; Rovira, M; Saldaña, R; Kwon, M; Solano, C; Valcárcel, D; Pascual-Cascón, MJ; Noriega, V; Sanz, J; Sánchez-Salinas, A; Jurado, M; Calbacho, M; Bento, L; López, CA; Perera, M; Heras, I; Guerreiro, M; Balsalobre, P; Armand, P; Sureda, A; Mussetti, A.

Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study

Blood Advances. 2026; 10(6): 1843-1853 Nº de citas: 1 [doi:10.1182/bloodadvances.2025018152]

Passamonti, F; Foran, JM; Tandra, A; De Stefano, V; Fox, ML; Mattour, A; McMullin, MF; Perkins, AC; Rodriguez-Macías, G; Sibai, HA; Polepally, AR; Sun, Y; Chopra, AS; Harb, JG; Qin, Q; Potluri, J; How, J.

Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE)

HEMATOLOGICAL ONCOLOGY. 2026; 44(2): [doi:10.1002/hon.70180]

Sánchez-Maldonado, JM; Macauda, A; Cabrera-Serrano, AJ; Thomsen, H; Güler, M; Horst, RT; van Guelpen, B; Vodicka, P; Landi, S; Chattopadhyay, S; Ünal, P; Ruiz-Durán, L; Casabonne, D; Goldschmidt, H; Serin, I; Carretero-Fernández, M; Cabezudo, E; Reyes-Zurita, F; Norman, AD; García-Sanz, R; Capurso, G; Hoffmann, P; Pettersson-Kymmer, U; Jiménez-Romera, F; Rajkumar, SV; Weinhold, N; Vodickova, L; Langer, C; Stein, A; Karismaz, A; Moreno, V; Nöthen, MM; Jöckel, K; Tavano, F; Martínez-López, J; Kumar, SK; Gutiérrez-Bautista, JF; Basso, D; Späth, F; Benavente, Y; Hildebrandt, MAT; Schmidt, B; Sevcikova, T; Reis, RMV; Li, Y; López-Nevot, MA; Netea, MG; Campa, D; Clay-Gilmour, A; Slager, SL; Hemminki, K; Vachon, CM; Försti, A; Canzian, F; Sainz, J.

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

INTERNATIONAL JOURNAL OF CANCER. 2026; : [doi:10.1002/ijc.70427]

Huguet M; Morgades M; Rivas-Delgado A; Bastos-Oreiro M; Córdoba R; Salar A; de la Cruz-Vicente F; Alcoceba M; Ferrer-Lores B; Jiménez-Ubieto A; Gutiérrez A; Infante M; Huerga S; Abrisqueta P; Cruz D; Montalbán C; Muntañola A; Villambrosia SG; Ribera JM; Navarro JT.

Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.

BRITISH JOURNAL OF HAEMATOLOGY. 2026; 208(3): 1111-1115 [doi:10.1111/bjh.70287]

Ortiz-Maldonado, V; Martinez-Cibrian, N; Alserawan, L; Español-Rego, M; Navarro-Velázquez, S; Albiol, N; Oliver-Caldés, A; Triguero, A; Herrero-Garcia, M; Gutiérrez-Herrero, S; Benitez-Ribas, D; Paciello, ML; Torrent, A; Delgado-Serrano, J; Sánchez-Castañón, M; Calderón, H; Mata, JJ; Sánchez-Salinas, A; Sáez-Peñataro, J; Sans-Pola, C; Calvo-Orteu, M; López-Corral, L; Kwon, M; Rifón, J; Charry, P; Alonso-Fernández, RA; Huguet, M; Blázquez-Goñi, C; Sánchez-Pina, JM; Sánchez, R; Rosa-Rosa, JM; Martinez-López, J; Blanquer, M; Ribera, JM; Urbano-Ispizua, A; Bachiller, M; Palau, L; Olesti, E; Calvo, G; Martin-Martin, L; Orfao, A; González-Navarro, EA; Domenech, G; Varea, S; Juan, ME; Delgado, J; Esteve, J.

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial

Lancet Haematology. 2026; 13(3): 133-143 [doi:10.1016/S2352-3026(25)00328-X]

Moure, BG; Khayat, S; Acosta, DF; Cuéllar, IN; Muela, CM; López, AL; Rial, MT; de Frutos, GA; Martínez, CM; Antúnez-Conde, R; Troise, S; Vaira, LA; Orabona, GD; Ochandiano, S; de Atalaya, FJL; Salmerón, JI; Cuéllar, CN.

Beyond Accuracy: Perioperative Efficiency and Institutional Cost Implications of CAD/CAM-Guided Versus Conventional Freehand Fibula Free Flap Reconstruction for Mandibular and Maxillary Defects

Journal of Clinical Medicine. 2026; 15(5): [doi:10.3390/jcm15051778]

Mingot-Castellano ME; Pardos-Gea J; Rico AM; Alcalde-Mellado P; Salvadores-Alvares V; Jimenes AJ; Hirnyk MC; Gutierrez AB; Bastida JM; Alén JAR; Candel FG; Penella DT; Quintana AM; Navarro GAM; Palmer ER; Expósito MC; Correa SA; Miñana LT; Garcia JAR; Alvarez-Roman MT; Garcia RL; Gonzalez RR; Antoran JMM; Escobar NA; Culebras RA; Badás MPM; Antonio SM; Barrientos MU; Mosteirin NF; Sanchez MP; Herrero SV; Santiago CC; Miranda IC; Mañas MAP; Fernandez IV; Izquierdo CP; Lopez SC; Vera PM.

Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR).

Haematologica-The Hematology Journal. 2026; 111(2): 756-759 [doi:10.3324/haematol.2025.288480]

Bailén, R; Fernández-Villalobos, M; Alonso, S; Gómez-Centurión, I; Fernández-Caldas, P; Castilla, L; Llácer, MJ; Ahumada, A; Iniesta, C; Rincón, D; Muñoz, C; Sabell, S; Carbonell, D; Anguita, J; García-Sanz, R; Bañares, R; Kwon, M.

Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide

Frontiers in Immunology. 2026; 16: 1699219-1699219 [doi:10.3389/fimmu.2025.1699219]

Pérez-Lamas, L; Manzanares, M; Boluda, JCH; Montero, LFC; Casares, MTG; Ayala, R; Xicoy, B; Marin, FF; Ortí, G; Arias, RD; Prendes, SO; Lopez, RP; Mora, E; Nuño, CR; Velasco, AJ; Boqué, C; Pacho, MS; Lopez, JM; Carreño-Tarragona, G; Coiras, M; Garcia-Gutierrez, V.

One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib

ANNALS OF HEMATOLOGY. 2026; 105(2): [doi:10.1007/s00277-026-06806-7]

Rodríguez, BH; Navarro, PG; González, PV; Colino, CG.

Experience in the approach to adolescents with cancer in a multidisciplinary unit. Growing together

EUROPEAN JOURNAL OF PEDIATRICS. 2026; 185(2): [doi:10.1007/s00431-026-06747-3]

Rosa, AA; Carolina, AP; Marta, AV; Francisco, A; Adriana, FG; Natalia, G; Pablo, LL; Cristina, MF; Lydia, MS; Ulrike, N; Marina, S; Guillermo, HT; Henar, CG; Ana, GOD.

Experience of a Referral Center with Desmoid Tumors, Part 2: A Retrospective Analysis of 109 Cases

Cancers. 2026; 18(2): [doi:10.3390/cancers18020305]

García-Vicente, R; Rodríguez-García, A; Ancos-Pintado, R; Arroyo, A; Ortega-Hernández, A; Bragado-García, I; Castellano, E; Ortiz-Ruiz, A; Navarro-Aguadero, MA; Modrego, J; Leivas, A; García-Villalba, R; Tomás-Barberán, FA; Sánchez-Pina, JM; Alonso, R; Cedena, MT; Hernández-Sánchez, M; Carpio, C; Barba, P; Carbonell, D; Kwon, M; Bastos-Oreiro, M; García-Sancho, AM; Jiménez-Ubieto, A; Valeri, A; Gómez-Garre, D; Martínez-López, J; Linares, M.

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma

CLINICAL CANCER RESEARCH. 2026; 32(2): 375-389 [doi:10.1158/1078-0432.CCR-25-1676]

Lozano-Gil, JM; Rodríguez-Ruiz, L; Palacios, M; Peral, J; Navarro, S; Fuster, JL; Beléndez, C; Jérez, A; Murillo-Sanjuán, L; Díaz-de-Heredia, C; López-de-Hontanar, G; Zubicaray, J; Sevilla, J; Ferrer-Marín, F; Sepulcre, MP; Cayuela, ML; García-Moreno, D; Martínez-López, A; Tyrkalska, SD; Mulero, V.

TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome

EMBO Molecular Medicine. 2026; 18(2): 702-724 [doi:10.1038/s44321-025-00368-3]

García-Cadenas, I; Guerreiro, M; Yañez, L; Chorao, P; Martin, F; Suárez-Lledó, M; Pérez, A; Tomás, LG; López, J; Marsal, J; Romero, N; Huguet, M; Zabalza, A; González-Vicent, M; Vázquez, L; Silva, P; Gil, D; Micó-Cerdà, M; Sánchez, P; Filaferro, S; Balsalobre, P; Ubieto, AJ; Martino, R; Piñana, JL.

Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study

EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(4): 450-457 [doi:10.1111/ejh.70109]

Duque, P; Esteban, ML; Piñeiro, P; Ortiz-Lopez, A; Moreno-Carbonell, M; Lancho, P; Calvo, A; Terradillos, E; Pascual-Izquierdo, C.

Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia

BLOOD COAGULATION & FIBRINOLYSIS. 2026; 37(1): 28-37 Nº de citas: 1 [doi:10.1097/MBC.0000000000001400]

Benítez-Carabante, MI; López, AM; Oficialdegui, MLU; Bieler, CB; Romero, MP; Fornieles, MP; Fuentes, C; Enríquez, SV; Silva, GG; Duarte, ML; Hurtado, JMP; Torrent, M; García, LA; Diaz-de-Heredia, C.

Unrelated donor transplantation offers a real curative opportunity for patients with transfusion-dependent thalassaemia. A multicenter retrospective study on behalf of the Spanish group for hematopoietic transplantation and cellular therapy (GETH-TC)

CYTOTHERAPY. 2026; 28(1): 101989-101989 [doi:10.1016/j.jcyt.2025.09.012]

Fernández-Luis S; Bermúdez A; Yáñez San Segundo L; Baile González M; Marcos Asensio S; Esquirol A; García-Cadenas I; Pascual MJ; Herruzo B; Salas MQ; Alburquerque-Prieto C; Viguria-Alegría MC; Pérez A; Hernani R; Huguet Mas M; Villalba M; Martín Calvo C; Fabbri N; González-Rodriguez AP; Bailén R; García Tomás L; García Maño L; Sánchez Salinas A; Calbacho M; Bento L; Sureda Balari A.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

TRANSPLANTATION. 2026; 110(1): 243-253 Nº de citas: 2 [doi:10.1097/TP.0000000000005446]

García-Sanz, R; Owen, RG; Jurczak, W; Dimopoulos, MA; McCarthy, H; Cull, G; Opat, SS; Castillo, JJ; Kersten, MJ; Wahlin, BE; Grosicki, S; Prathikanti, R; Tian, T; Allewelt, H; Cohen, AC; Tam, CS.

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study

Blood Advances. 2025; 9(24): 6538-6546 [doi:10.1182/bloodadvances.2024015596]